Bold

Investment decisions are led by Co-founder and Managing Partner David Dufresne alongside Managing Partner Jean de La Rochebrochard. The partnership structure involves both partners in investment committee deliberations, though the firm has not publicly detailed the precise voting mechanics or IC composition. Dufresne has led the firm since its 2010 founding and is the most visible external representative at European venture events.

Bold sources primarily through partner networks built over a decade of European seed investing, including founder referrals, developer community events, and direct outreach to technical teams at universities and research labs. The firm's Paris base gives it access to French engineering talent pipelines, while partner travel to London, Berlin, and Stockholm extends sourcing reach. Bold has not disclosed a formal scout program or campus ambassador network.

Bold targets pre-seed and seed rounds exclusively, writing first institutional checks before companies have product-market fit, revenue, or in some cases formal incorporation. The firm does not invest in Series A or later stages, maintaining a discipline that distinguishes it from many European peers who have expanded into growth equity to capture faster mark-ups. Typical initial check sizes are in the low single-digit millions of euros.

Bold invests through direct equity deals into startup operating companies and does not publicly operate a fund-of-funds or LP commitment program into other venture firms. The firm leads or co-leads seed rounds and occasionally participates alongside other seed-stage specialists, but all capital is deployed into portfolio companies directly rather than through intermediary fund vehicles.

Bold has not published a formal negative investment list, but public record of portfolio holdings shows no activity in hard tech, defense, space technology, or life sciences requiring FDA or EMA regulatory pathways. The firm concentrates on software-centric business models where product iteration cycles are fast and capital requirements for initial product development are lower than in hardware or therapeutics.

Bold operates from a single headquarters in Paris, France, without disclosed additional offices. However, the partnership actively invests across Western Europe, with known portfolio activity in France, the United Kingdom, Germany, and the Nordic region. The managing partners maintain personal presence in London, Berlin, and Stockholm through frequent travel, though the firm has not established subsidiary legal entities outside France.

Bold has not publicly disclosed any philanthropic foundation or impact investing vehicle linked to the partnership. The firm operates as a conventional venture capital manager with a for-profit mandate and has not signaled an intention to add a mission-related or program-related investment arm. Any personal giving by the named principals would be separate from the managed fund vehicles.